Please login to the form below

Not currently logged in
Email:
Password:

McCann Health joins Spanish advertising agency network

Marketing firm signs up to Spanish Association of Advertising Agencies of Health (AEAPS)
McCann Health logo

The association represents the main healthcare communications agencies active in Spain – members include Havas Health, Ogilvy Healthworld and Sudler & Hennessey.

Part of McCann WorldGroup, McCann Health is a network of health communications agencies, and has been active in Spain for the last 15 years, with offices in Madrid and Barcelona. By joining AEAPS, it hopes to reinforce market awareness of its work, client services director Loris Marchet told PMLiVE.

“We want to continue to be perceived as a healthcare specialised company even more now that the compliance with the ethical code of Farmaindustria is a must-have that clients are asking for. And the relation between AEAPS with Farmaindustria is very close,” he said.

“We also want to increase contact with stakeholders through activities such as education and forums, and AEAPS gives us the opportunity do so. Finally, it's very important that the specialised health advertising industry joins forces, to show themselves as key players in health marketing.”

McCann Health Spain's clients include Novartis, Boehringher Ingelheim and Abbott. Recent projects include work for Boehringer's respiratory business, creating awareness of cardiovascular care for the ProCnic foundation and oncology and rheumatoid arthritis projects for Roche and BMS.

"We are proud that an agency with the category and the trajectory of Health McCann has joined our association. We are confident that McCann's contribution will be key to our work to ensure high-quality health communications", said AEAPS president Lourdes Paul.

Article by
Tara Craig

9th April 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics